Design, Synthesis of 3‐ n ‐Butylphthalide‐Hydrazine/Hydrazide Derivatives as Potential Anti‐Ischemic Stroke Agents
Chemistry & Biodiversity · 2026
DOI: 10.1002/cbdv.71866 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2026. Verfasst von Yong Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine & School of Pharmaceutical Sciences, Guizh…. Hauptthemen laut MEDLINE: Benzofurans, Hydrazines, Drug Design, Ischemic Stroke. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Guizhou Medical University High-Level Talents Research Initiation Fund Project, Science and Technology Fund Project of Guizhou Provincial Health Commission.
Themen: Schlaganfall
Abstract (Originalsprache)
To identify novel therapeutic candidates for ischemic stroke, a series of hydrazine‐ and hydrazide‐derived analogs based on 3‐ n ‐butylphthalide (NBP) were designed and synthesized in this study, and their anti‐ischemic stroke activities were systematically assessed. Among all synthesized derivatives, the compound NBP‐HY exerted potent antiplatelet aggregation and antioxidant activities in vitro. Consistent in vivo results revealed that NBP‐HY significantly alleviated thrombus formation in both carrageenan‐induced tail thrombosis and FeCl 3 ‐induced carotid artery thrombosis models. In a rat middle cerebral artery occlusion/reperfusion (MCAO/R) injury model, NBP‐HY markedly reduced cerebral infarct volume, improved cerebral blood perfusion, and protected hippocampal CA1 and cortical neurons, exhibiting superior therapeutic efficacy compared with the lead compound NBP. Further pharmacological experiments showed that NBP‐HY exhibits moderate metabolic stability in liver microsomes, good blood–brain barrier permeability in the PAMPA‐BBB model, and minimal impact on mice's physiological hemostatic function. Collectively, this work indicates that NBP‑HY has potential as a therapeutic candidate for ischemic stroke and warrants further in‑depth investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine & School of Pharmaceutical Sciences, Guizhou Provincial Key Laboratory of Innovation and Manufacturing for Pharm…
ORCID-Profile: Lingling Fan
Förderung
- National Natural Science Foundation of China
- Guizhou Medical University High-Level Talents Research Initiation Fund Project
- Science and Technology Fund Project of Guizhou Provincial Health Commission
- Guizhou Provincial Maior Scientific and Technological Program
- the High-Level Innovative Talents Fund of Guizhou Province
Zitieren
APA
Li, Y., Wang, M., Zhang, Q., Zhou, P., Yang, Y., Tang, L., Fan, J., & Fan, L. (2026). Design, Synthesis of 3‐ n ‐Butylphthalide‐Hydrazine/Hydrazide Derivatives as Potential Anti‐Ischemic Stroke Agents. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.71866
Vancouver
Li Y, Wang M, Zhang Q, Zhou P, Yang Y, Tang L, et al. Design, Synthesis of 3‐ n ‐Butylphthalide‐Hydrazine/Hydrazide Derivatives as Potential Anti‐Ischemic Stroke Agents. Chemistry & Biodiversity. 2026. doi:10.1002/cbdv.71866
BibTeX
@article{Li2026,
author = {Li, Yong and Wang, Manju and Zhang, Qing and Zhou, Pengfei and Yang, Ya and Tang, Lei and Fan, Judi and Fan, Lingling},
title = {Design, Synthesis of 3‐ n ‐Butylphthalide‐Hydrazine/Hydrazide Derivatives as Potential Anti‐Ischemic Stroke Agents},
journal = {Chemistry & Biodiversity},
year = {2026},
doi = {10.1002/cbdv.71866}
}
EUVIMED